117 related articles for article (PubMed ID: 14729624)
41. Overexpression of glycine-extended gastrin inhibits parietal cell loss and atrophy in the mouse stomach.
Cui G; Koh TJ; Chen D; Zhao CM; Takaishi S; Dockray GJ; Varro A; Rogers AB; Fox JG; Wang TC
Cancer Res; 2004 Nov; 64(22):8160-6. PubMed ID: 15548680
[TBL] [Abstract][Full Text] [Related]
42. Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence.
Smith AM; Watson SA
Gut; 2000 Dec; 47(6):820-4. PubMed ID: 11076881
[TBL] [Abstract][Full Text] [Related]
43. Growth-promoting effects of glycine-extended progastrin.
Seva C; Dickinson CJ; Yamada T
Science; 1994 Jul; 265(5170):410-2. PubMed ID: 8023165
[TBL] [Abstract][Full Text] [Related]
44. Predicting lung cancer prognosis using machine learning.
Burki TK
Lancet Oncol; 2016 Oct; 17(10):e421. PubMed ID: 27569440
[No Abstract] [Full Text] [Related]
45. Metabolism and influence of glycine-extended gastrin on gastric acid secretion in man.
Palnaes Hansen C; Stadil F; Rehfeld JF
Digestion; 1996; 57(1):22-9. PubMed ID: 8626044
[TBL] [Abstract][Full Text] [Related]
46. Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer.
Sepesi B; Nelson DB; Mitchell KG; Gibbons DL; Heymach JV; Vaporciyan AA; Swisher SG; Roszik J
Ann Thorac Surg; 2018 Jun; 105(6):1621-1626. PubMed ID: 29510096
[TBL] [Abstract][Full Text] [Related]
47. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis.
Ohta Y; Oda M; Wu J; Tsunezuka Y; Hiroshi M; Nonomura A; Watanabe G
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):900-6. PubMed ID: 11689794
[TBL] [Abstract][Full Text] [Related]
48. Glycine-extended progastrin processing intermediates: accumulation and cosecretion with gastrin.
Sugano K; Park J; Dobbins WO; Yamada T
Am J Physiol; 1987 Oct; 253(4 Pt 1):G502-7. PubMed ID: 2889366
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of CD151 overexpression in non-small cell lung cancer.
Kwon MJ; Seo J; Kim YJ; Kwon MJ; Choi JY; Kim TE; Lee DH; Park S; Shin YK; Han J; Choi YL
Lung Cancer; 2013 Jul; 81(1):109-16. PubMed ID: 23570797
[TBL] [Abstract][Full Text] [Related]
50. Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer.
Haga Y; Hiroshima K; Iyoda A; Shibuya K; Shimamura F; Iizasa T; Fujisawa T; Ohwada H
Ann Thorac Surg; 2003 Jun; 75(6):1727-32; discussion 1732-3. PubMed ID: 12822607
[TBL] [Abstract][Full Text] [Related]
51. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
[TBL] [Abstract][Full Text] [Related]
52. CCK-B/gastrin receptors in human colorectal cancer.
Schmitz F; Otte JM; Stechele HU; Reimann B; Banasiewicz T; Fölsch UR; Schmidt WE; Herzig KH
Eur J Clin Invest; 2001 Sep; 31(9):812-20. PubMed ID: 11589724
[TBL] [Abstract][Full Text] [Related]
53. Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer.
Pruitt SL; Laccetti AL; Xuan L; Halm EA; Gerber DE
Br J Cancer; 2017 Mar; 116(6):717-725. PubMed ID: 28196065
[TBL] [Abstract][Full Text] [Related]
54. Expression and processing of gastrin in hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma.
Caplin M; Khan K; Savage K; Rode J; Varro A; Michaeli D; Grimes S; Brett B; Pounder R; Dhillon A
J Hepatol; 1999 Mar; 30(3):519-26. PubMed ID: 10190738
[TBL] [Abstract][Full Text] [Related]
55. Modulation of posttranslational processing of gastrin precursor in dogs.
Varro A; Nemeth J; Bridson J; Lonovics J; Dockray GJ
Am J Physiol; 1990 Jun; 258(6 Pt 1):G904-9. PubMed ID: 2360636
[TBL] [Abstract][Full Text] [Related]
56. Role of metallothionein expression in non-small cell lung carcinomas.
Dziegiel P; Jeleń M; Muszczyńska B; Maciejczyk A; Szulc A; Podhorska-Okołów M; Cegielski M; Zabel M
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():43-5. PubMed ID: 15638370
[TBL] [Abstract][Full Text] [Related]
57. Progastrin and its glycine-extended posttranslational processing intermediates in human gastrointestinal tissues.
Del Valle J; Sugano K; Yamada T
Gastroenterology; 1987 Jun; 92(6):1908-12. PubMed ID: 3569767
[TBL] [Abstract][Full Text] [Related]
58. Gastrin interferes with the differentiation of gastric pit cells and parietal cells.
Nakajima T; Konda Y; Izumi Y; Kanai M; Takeuchi T; Chiba T
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():3-9. PubMed ID: 11966518
[TBL] [Abstract][Full Text] [Related]
59. Gastrin in non-neoplastic pancreatic tissue from patients with and without gastrinomas.
Bardram L
Scand J Gastroenterol; 1990 Sep; 25(9):935-43. PubMed ID: 2218398
[TBL] [Abstract][Full Text] [Related]
60. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
Ping W; Jiang WY; Chen WS; Sun W; Fu XN
Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]